3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with gamma-glu-asp in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Barry, J; Mathis, C; Mélan, C; Ungerer, A | 1 |
1 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and gamma-glu-asp
Article | Year |
---|---|
The NMDA receptor antagonists, CPP and gamma-L-glutamyl-L-aspartate, selectively block post-training improvement of performance in a Y-maze avoidance learning task.
Topics: Animals; Avoidance Learning; Cell Membrane; Dipeptides; Dose-Response Relationship, Drug; Hippocampus; Male; Memory; Mice; Mice, Inbred Strains; Piperazines; Radioligand Assay; Receptors, N-Methyl-D-Aspartate; Tritium | 1991 |